Skip to Content

RadNet Inc RDNT

Morningstar Rating
$44.35 +6.49 (17.14%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

RDNT is trading at a 1% premium.
Price
$44.27
Fair Value
$12.83
Uncertainty
High
1-Star Price
$37.40
5-Star Price
$56.16
Economic Moat
Njmdq
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RDNT is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$37.86
Day Range
$39.7845.20
52-Week Range
$22.7045.20
Bid/Ask
$44.20 / $44.35
Market Cap
$3.01 Bil
Volume/Avg
2.0 Mil / 472,461

Key Statistics

Price/Earnings (Normalized)
130.17
Price/Sales
1.74
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments; Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures, and Artificial Intelligence segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company derives a majority of its revenue from the Imaging center segment.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Growth
Total Number of Employees
9,067

Comparables

Valuation

Metric
RDNT
CAJ
HLS
Price/Earnings (Normalized)
130.1719.432.30
Price/Book Value
4.862.090.81
Price/Sales
1.741.360.42
Price/Cash Flow
11.117.582.49
Price/Earnings
RDNT
CAJ
HLS

Financial Strength

Metric
RDNT
CAJ
HLS
Quick Ratio
1.300.520.44
Current Ratio
1.420.570.53
Interest Coverage
1.62−1.07−13.26
Quick Ratio
RDNT
CAJ
HLS

Profitability

Metric
RDNT
CAJ
HLS
Return on Assets (Normalized)
2.19%1.77%0.10%
Return on Equity (Normalized)
12.51%3.72%0.23%
Return on Invested Capital (Normalized)
4.81%3.34%2.27%
Return on Assets
RDNT
CAJ
HLS
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncKlzbh$219.8 Bil
DHR
Danaher CorpBsqblk$189.3 Bil
IDXX
IDEXX Laboratories IncMldrmvc$47.9 Bil
IQV
IQVIA Holdings IncDddqfzf$45.9 Bil
A
Agilent Technologies IncFbmrv$40.8 Bil
MTD
Mettler-Toledo International IncKyqrqy$27.2 Bil
ICLR
Icon PLCKhyzhtk$26.9 Bil
ILMN
Illumina IncNfxdvhz$22.3 Bil
WAT
Waters CorpRjrl$20.5 Bil
LH
Laboratory Corp of America HoldingsMvtnh$18.3 Bil

Sponsor Center